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Indications and Technique for 
Permanent Cardiac Pacemaker 
Implantation in the Dog 
Susan M. Kimm, BS· 
Brian L. Hill, DVM, MS** 
Electrical pacing of the heart has been uti-
lized in human medicine for more than two 
decades. Cardiac pacing was used initially for 
cases of complete heart block that were 
unresponsive to medical therapy. During the 
14-year period following the first human im-
plant in 1958, an estimated 120,000 units were 
implanted with 60 % of patients being over 65 
years old and with a 50-60 % survival rate five 
years after implantation. 1 Permanent 
pacemakers are also utilized in dogs at various 
veterinary practices. The purpose ofthis paper 
is to review clinical indications for pacemakers 
in the dog as well as potential complications 
encountered with their use; to identify the 
types of units available and indicate how to 
select a given pacemaker for a given clinical 
syndrome; and to review the surgical techni-
que for implantation along with follow-up 
surveillance. 
In a 1979 survey of dogs with pacemakers, 
miniature schnauzers were by far the most 
common breed, comprising 26% of total 
cases.1 Other breeds were evenly distributed 
with German shepherds, poodles, Boston ter-
riers, Yorkshire terriers, and mix-breed dogs 
represented. The mean age was 8.5 years with 
a range from 3 to 15 years, and the male to 
female ratio was nearly equal (52 % to 48%). 
Third degree heart block was diagnosed elec-
trocardiographically in 55 % of the dogs. Sick 
sinus syndrome was diagnosed in 26 % of the 
dogs with electrocardiographic abnormalities 
including marked sinus arrhythmia or brady-
cardia and temporary sinus arrest or sinus exit 
block. The remaining 19 % of the dogs had 
persistent atrial standstill. The primary 
presenting complaint was syncope which was 
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cited in 81 % of cases. Nonspecific weakness 
was a complaint in 71 % of the dogs, and 29% 
presented with ataxia. 
INDICATIONS FOR 
CARDIAC PACING 
Electrical cardiac pacing is most frequently 
indicated as a treatment for bradyarrhythmias 
that are accompanied by such clinical signs as 
syncope, weakness, and decreased exercise tol-
erance. 3 .4.5 Complete atrioventricular (A V) 
block, sick sinus syndrome, permanent atrial 
standstill, and persistent ventricular ar-
rhythmias are the primary cardiac conditions 
in which pacemaker implantation is war-
ranted;J.4·s each will be discussed in detail. 
Acute myocardial infarction resulting in 
bradyarrhythmias due to conduction disturb-
ances has also been advocated as an indication 
for cardiac pacing in man,s although myocar-
dial infarction is quite infrequent in the dog_ 6 
Complete (third degree) heart block may be 
caused by fibrosis and degeneration of the 
atria or A V junctional tissue, congenital 
damage to the conduction system, natural or 
idiopathic myocardial trauma, vagal stimula-
tion, hypoxia, inflammation or infectious pro-
cesses such as bacterial endocarditis, tox-
emias, hyperkalemia, infiltrative car-
diomyopathies due to neoplasia or 
amyloidosis, hypertrophic cardiomyopathy, 
or severe digitalis toxicity. 4.5.7.8 Complete A V 
block, except when caused by digitalis toxicity, 
is almost always associated with syncope and is 
a definite indication for cardiac pacing. 2.3.4.5. 7 
Syncopal episodes due to A V block have been 
referred to as Stokes-Adams syncope. 6 With 
classical Stokes-Adams syncope, a permanent 
ventricular rate of 30 to 40 beats/min is con-
trolled by a slow, relatively unstable idioven-
tricular pacemaker that may be affected by 
electrolyte changes, hypoxia, or acidosis. 8 .9 
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Syncope may then result due to decreased 
cerebral arterial perfusion pressure when 
cerebral blood flow is interrupted for 6 to 8 
seconds during an unstable ventricular 
rhythm.s A second type of complete AV block 
occurs less commonly in dogs which is tran-
sient and alternates with either normal sinus 
rhythm or first or second degree heart block. 8 
During the transition between the two alter-
nating rhythms, the latent pacemaker may fail 
to ImUate stable ventricular contraction 
resulting again in episodes of syncope.s 
Sick sinus syndrome (also called brady-
cardia-tachycardia syndrome or sinoatrial 
(SA) syncope) is a second major indication for 
permanent cardiac pacing in the dog. The 
etiology may involve disease of the SA nodal 
artery, infiltrative or inflammatory lesions 
around the SA node, or replacement of the SA 
node with fibrous tissue. It is suspected that a 
genetic mode of inheritance exists for the syn-
drome in female miniature schnauzers.4.lo•1I 
Hamlin documented two forms of sick sinus 
syndrome in dogs, both of which may cause 
syncope. IO In the first form, the sinus node 
does not depolarize, and presumably due to 
coexisting disease of the A V junction and 
peripheral Purkinje system, no ectopic 
pacemaker develops to initiate an escape 
rhythm.4.9 •,0 The result is cardiac standstill, 
cerebral ischemia, and syncope.9 •10 In the se-
cond form of sick sinus syndrome, sinus arrest 
occurs due to overdrive suppression by a burst 
of supraventricular tachycardia immediately 
preceeding the arrest. After sudden cessation 
of the rapid atrial pacing by the tachycardia, 
the sinus node and junctional pacemaker re-
main suppressed and arrested for up to 20 
seconds before an escape pacemaker arises. 8•,0 
Once again, permanent cardiac pacing is the 
treatment of choice for symptomatic 
patients.2.3.4.5.7 
A third indication for pacemakers in the dog 
is persistent atrial standstill, or "silent 
atrium."4 Electrocardiographic characteristics 
include absence of P waves and a regular 
supraventricular escape rhythm that is usually 
less than 60 beats/min. 4 .7 Clinical signs may 
include syncope, weakness, and congestive 
heart failure, and if present , warrant electrical 
pacing.4 
Fourth, life threatening ventricular ar-
rhythmias that are refractory to medical 
therapy may often be controlled by overdrive 
electrical pacing.'2.'3.'4.'5.'6 Increasing heart 
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rate decreases refractory period, diminishes 
heterogenicity in repolarization of adjoining 
fibers, and increases the threshold for fibrilla-
tion; as a result, suppression of automaticity 
occurs and the frequency of ectopic ventricular 
beats decreases. 12 Ectopic beats accompanying 
bradycardia due to advanced degrees of heart 
block,13 Stokes-Adams seizures due to ven-
tricular tachycardia and heart block,'4 
reciprocating ventricular tachycardia,'5 and 
recurrent ventricular fibrillation '6 have been 
effectively controlled by overdrive cardiac 
pacemakers. 
PACEMAKER UNITS: COMPONENTS, 
'MODES, AND SELECTION 
Permanent pacemakers consist oftwo major 
components: a pulse generator and an elec-
trode wire that connects the pulse generator to 
the heart. The power source for the 100 to 200 
gm pulse generator is usually a battery of 4 or 
5 individual mercuric oxide zinc cells in series 
or series-parallel. I With the unipolar electrode 
system used in dogs, only one electrode, the 
cathode, contacts the heart. The other "in-
different" electrode is a large metal plate sur-
rounding the pulse generator. 1 Pulse 
generators are nonallergenic, nontoxic, and 
noncarcinogenic, so they generally are well ac-
cepted by the body, I although tissue rejection 
has been documented in both man and dogs. 2 
There are currently over 30 types of pace-
makers manufactured, with each being de-
signed for a specific syndrome or combination 
of clinical signs. , ,4,5 The various types fall 
generally into two categories: asynchronous 
(fixed-rate) and synchronous (non-
competitive). Synchronous pacemakers are 
further subdivided into ventricular inhibited 
(demand) pacemakers and ventricular trig-
gered (standby) pacemakers. A 3-letter code 
has been suggested to identify the mode of 
operation of a pulse generator with the first let-
ter representing the chamber(s) paced 
(A =0 atrium, V =0 ventricle, and D =0 both), 
the second letter representing the chamber 
sensed, ifany, (A =0 atrium, V =0 ventricle, and 
0=0 not applicable), and the third representing 
the mode of response (I =0 inhibited, 
T =0 triggered, and 0 =0 not applicable).' Using 
the code, VOG units pace the ventricles at a 
fixed rate without any sensing activity, while 
VVI units sense intrinsic R waves and inhibit 
a pacing spike for a short delay, 
The earliest type of pacemaker developed 
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was the fixed-rate (asynchronous, com-
petitive) pacemaker which stimulated the 
heart at a constant rate, regardless of inherent 
cardiac rhythm. I . II • 17 The rate in adjustable 
asynchronous units may be reset by needle 
control potentiometers or magnetic or encoded 
impulses to increase or decrease rate, but the 
rate is insensitive to physiologic signals. I . 17 
Fixed-rate pacemakers are most ap-
propriately used in cases where the return to 
sinus rhythm is unlikely or where the ven-
tricles do not receive any intrinsic supraven-
tricular impulses. When improperly used in 
othcr conditions, competition between in-
herent and paced cardiac rhythms may present 
a danger if the paced stimulus falls within the 
"vulnerable period" of a preceding cycle and 
evokes a serious dysrhythmia such as ven-
tricular fibrillation. 9.10 When dealing with 
dogs that have intermittent tachycardia, as in 
certain cases of sick sinus syndrome, asyn-
chronous pacemakers cannot be recommend-
ed. Instead, ventricular inhibited pacemakers 
should be utilized since the pacing circuitry in 
these units resets until after the dangerous 
vulnerable phase of the sensed beat. 9.10 
Although asynchronous pacemakers normally 
have a safety margin in that the energy 
delivered for pacing (5 to 10 joules) is only 
10% of that required for fibrillation threshold, 
electrolyte imbalances or drug toxicities may 
negate this margin, increasing potential for 
serious dysrhythmia. I . 17 
In animals with spontaneous cardiac activi-
ty, synchronous ( noncompetitive) pacemakers 
are indicated because of their ability to detect 
intrinsic cardiac rhythm and alter their output 
accordingly. 1 In this way, potentially 
dangerous competition between endogenous 
and paced rhythms in cases of sick sinus syn-
drome with intermittent tachycardia or persis-
tent ventricular arrhythmias is avoided. The 
output of a pacemaker operating in a non-
competitive mode is either inhibited or trig-
gered by a sensed signal, which may be 
detected in either the atrium or ventricle 
depending on the position of the sensing elec-
trode. Ventricular inhibited (VVI) units are 
the most commonly used type of demand 
pacemaker in dogs to this date. J These units 
pace the heart only when the patient's ven-
tricular rate drops below the preset rate of the 
unit; when the heart rate is above that level, 
the presence of an endogenous QRS complex 
with an amplitude of at least 0.5 to 2 m V sup-
Vol. 45, No. 1 
presses the output of the pulse generator for 1 
cycle. 1.5 A more complex unit, the biofocal or 
A V sequential demand pacemaker (DVI), 
senses ventricular activity and sequentially 
paces the atrium and then the ventricle on 
demand. I .5 Although A V synchrony is 
restored by the DVI unit, the fact that both 
atrial and ventricular electrodes are utilized 
usually precludes its usc even in human medi-
cine since atrial electrodes are difficult to posi-
tion and likely to dislodge. 1 
The second category of synchronous pace-
makers includes the ventricular triggered 
(standby) pacemaker (VVT). This type of unit 
avoids competitive rhythms by sensing an in-
trinsic QRS complex and immediately dis-
charging into the refractory period of the 
heart. 4 •5 •17 Hno QRS complex is detected, the 
VVT unit discharges after its preset escape in-
terval to assure a minimum ventricular 
rate. 1 . 5 . 17 In contrast to the VVI pacemaker, 
the VVT pacemaker is not inhibited by ex-
traneous electromagnetic interference .1 •5 
SURGICAL IMPLANTATION 
Preoperative evaluation of surgical can-
didates for permanent pacemaker implanta-
tion should include a thorough physical exam, 
complete blood count, serum biochemical 
profile, and thoracic and abdominal 
radiographs. 2 Yoshioka found that temporary 
cardiac pacing for 24 to 48 hours before 
surgery via a transvenous pacing electrode in 
the right ventriele and an external pulse 
generator was important both in stabilization 
Pacemaker with myocardial electrode inserted in 
handle for implantation. 
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of the patient pre- and intra-operatively, and 
in determining the success of electrical pacing 
by monitoring clinical response and repeated 
electrocardiograms. 2 
There are two basic methods in which elec-
trical stimulation is applied to the heart. 2.11 
The electrode may either be inserted 
transvenously, via the external jugular vein, 
into the endocardial surface of the right 
ventricle,I1·17 or it may be sutured or screwed 
into the epimyocardial surface of the left ven-
tricle, necessitating a thoracotomy. 2.4.11 The 
pulse generator is connected to the electrode 
and placed in a pocket between muscle layers, 
either in the left flank between abdominal obli-
ques or dorsal to the scapula. 2.11 .17 In animals 
weighing 5 kg or less, the pulse generator may 
be too large to fit in these sites, so it can be 
placed in the cranial abdomen and allowed to 
sit unattached. 2 
The transvenous implantation technique 
has been described by Musselman, et al. 17 No 
preoperative temporary pacemaker was avail-
able and general anesthesia was considered 
hazardous in the patient described, so the dog 
was heavily sedated. In this technique, the left 
jugular vein is isolated by blunt dissection, 
ligated distally, and a temporary ligature is 
placed around the proximal segment. A stab 
incision is made between the ligatures and the 
electrode is passed, with the aid of fluoroscopy, 
Enlarged photo of the electrode of a myocardial 
implantation -type pacemaker. 
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into the right ventricular apex and wedged 
under a trabeculum. Two nonabsorbable liga-
tures are then placed around the proximal 
jugular segment that contains the electrode. 
After making a subcutaneous pocket near the 
dorsal scapula and a subcutaneous tunnel to 
the proximal jugular segment, the pulse 
generator and electrode are connected and 
secured with nonabsorbable sutures . Finally, 
the pulse generator is secured with nonab-
sorable sutures in its pocket, and the skin is 
closed routinely . 17 Care must be taken to avoid 
excessive tension on the muscles and skin 
overlying the pulse generator, as pressure 
necrosis with secondary infection has led to 
fatal septicemia and chronic fistula formation 
necessitating removal of infected electrodes in 
man .2.11.18 
Although a transvenous electrode does not 
necessitate a thoracotomy, there are problems 
that make it less desirable than an epimyocar-
dial lead. First, the incidence of dislodgment is 
greater with transvenous e1ectrodes. 19 The 
canine right ventricle has less trabecular net-
work than the human heart so there is more 
difficulty wedging the electrode tip under tra-
beculae to capture good pacing contact. J Also, 
the normal movement of quadrupeds increases 
the likelihood of dislodgment with endocardial 
leads. 2.19 The second major problem with 
transvenous electrodes is that they may in-
terfere with cardiac and pacemaker function 
due to consistent morphological changes they 
induce. 18.19 Pathologic cardia changes, which 
appear to be due to the presence of foreign 
material in the heart rather than external 
stimulation of the heart, include connective 
tissue sheath formation around the electrode, 
endocardial papillary thickening, interatrial 
septal changes, and myocardial damage. His-
tologically there is cartilaginous metaplasia in 
the endocardium and underlying myocardium 
with marked cellular proliferation. 19 In addi-
tion to interfering with function, the entrap-
ment of the electrode and catheter makes 
withdrawal dangerous to impossible after ap-
proximately 6 to 8 weeks due to potential com-
plications such as right ventricular rupture or 
ventricular fibrillation. 18 In the event of persis-
tent infection or migration of trans venous elec-
trodes, a thoracotomy is recommended for re-
moval. 18 
For implantation of myocardial electrodes, 
entry into the thoracic cavity is made at the 
ventral third of the left fifth or sixth intercostal 
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Radiograph of implantation-type pacemaker in place. 
space to expose the left ventricle. 2 A sutureless 
"corkscrew" electrodea is available that is 
mounted on a special handle for rotation into 
the myocardium. 2.4 The pericardium is incised 
2 to 3 em to visualize coronary vessels, and the 
electrode is screwed clockwise into the left ven-
tricle avoiding the exposed vessels. 2 The elec-
trode is held in place by fibrous attachments to 
a polyester netting above the electrode tip.4 
Once implanted, the electrode is gently re-
leased from the handle and attached to the 
pulse generator through the seventh inter-
costal space with care that no tension is placed 
on the lead. 2 Alternatively, epimyocardial 
leads may be sutured to an avascular area of 
the left ventricle by 2 to 4 preplaced dacron 
polyester sutures approximately one-half way 
between the apex and base of the heart. 20 
FOLLOW-UP SURVEILLANCE 
Follow-up care is very important in pace-
maker recipients to determine proper function 
of the pulse generator and electrode. In the im-
mediate postoperative period, dogs are placed 
on a broad-spectrum antibiotic for 7 days, and 
an ECG is run every 12 hours for the first 48 
hours.2 Once stable, dogs may be discharged 
and kept initially in strict confinement at 
home. 2 Clients are shown how to take a pulse, 
and instructed to keep accurate daily records 
of pulse rate with weekly notes about appetite, 
"Mcdtronics suturcless myocardial pacing lead, model 
6917, Mcdtronics, Inc., Minneapolis. 
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body weight, water consumption, and activi-
ty. 2.3 At 2 weeks sutures are removed, and an 
ECG is run. 2 One month postoperatively 
thoracic radiographs and an ECG are taken to 
determine integrity and function of the pace-
maker and to check for migration of lead or 
pulse generator components. 2 Thereafter, 
dogs should be examined electrocardiogra-
phically every 3 to 6 months to monitor func-
tion and anticipate battery exhaustion, and ra-
diographs should be taken every 6 months. 2 
Caution must be taken for pacemaker reci-
pients with regard to the use of electrosurgical 
instruments during subsequent operative pro-
cedures and the use of direct-current defibril-
lators.' Electrocautery or cutting instruments 
as well as their ground plates should be kept at 
least 2 inches from implanted pulse genera-
tors, and electrical currents should only be ap-
plied in bursts separated by intervals of several 
seconds.'·3 The instruments may otherwise in-
hibit VVI pulse generators.' In addition, 
although pulse generators are relatively resis-
tant to direct-current defibrillation shock, they 
may be damaged by such currents.' It is 
therefore recommended that paddles be posi-
tioned as far from the pulse generator as 
possible. ' 
PACEMAKER MALFUNCTION 
AND COMPLICATIONS 
Pacemakers are often purchased from 
human hospitals or donated by manufacturers 
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after the shelf life has expired in order to keep 
costs practical for veterinary medicine. 2 .4 The 
most common cause of pacemaker failure is 
battery exhaustion. 4 Therefore, it is essential 
to detect signs of impending failure to allow for 
elective pulse generator replacement. In 
general, standard output units have a 24 to 36 
month life expectancy; however, im-
provements in battery cells are increasing 
longevity.· Specific end-of-life characteristics 
of an individual pulse generator should be ob-
tained from the manufacturer. Z 
Indications of impending battery failure in-
clude a reduction in artifact voltage, change in 
the shape and contour of the artifact, and 
change in pacemaker rate.· 1 A declining 
pacemaker rate is universally accepted as evi-
dence of battery end-of-life.· The sensing cir-
cuit of a synchronous pulse generator can be 
dcactivated by application of an external 
magnet over the unit, thus converting it to an 
asynchronous ("magnet") rate.· This magnet 
rate is the most reliable parameter for detec-
ting battery exhaustion in noncompetitive 
units.· The 15 to 30 seconds of competition 
produced by the magnet is not dangerous 
clinically. • 
In addition to replacement of the battery 
pack, other complications with implanted 
pacemakers may include migration of the 
pulse generator or electrode, wire breakage, 
electromagnetic interference (EMI), abscessa-
tion or infection, and postoperative 
arrhythmias. 3 If a wire fracture is suspected, 
radiography with an overpenetrating techni-
que may reveal the site, but more sophisticated 
systems such as electronic waveform analysis 
are usually necessary to confirm a break.· 
Although noncompetitive pacemakers with a 
sensing circuit may pick up electromagnetic 
interference from sources such as microwave 
ovens, small electric motors, and skeletal mus-
cle potentials, these sources do not constitute a 
significant clinical problem due to shielding of 
pulse generators with titanium or stainless 
steel. • Postoperative arrhythmias encountered 
in pacemaker recipients are usually easily con-
trolled with antiarrhythmic drugs and do not 
persist. 3 
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